Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
About Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Eli Lilly and Company
2
AstraZeneca
1
Clinical Trials at Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
During the past decade, Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on
average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
2014-03-27
2021-04-16
Completed
389
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
2015-10-07
2019-08-20
Completed
2,171
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
2017-03-15
2018-10-02
Terminated
421
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
2018-05-28
2026-12-04
Active, not recruiting
927
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz"
#1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
According to Clinical.Site data, the most researched conditions in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are
"Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Migraine" (1 trials) and "Migraine Disorders" (1 trials). Many other conditions were trialed in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" in a lesser frequency.
Clinical Trials Intervention Types at Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
Most popular intervention types in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (4 trials), "Gantenerumab" (3 trials), "Fenebrutinib" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
The vast majority of trials in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz" are
12 trials for "All" genders.
Clinical Trials Status at Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz
Currently, there are NaN active trials in "Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Studienzentrum Nordwest, Dr. med. Joachim Springub / Herr Wolfgang Schwarz, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".